LOC100133991 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.414600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.711200E-01
Normal-vs-Stage2
4.489600E-01
Normal-vs-Stage3
1.674560E-01
Normal-vs-Stage4
8.330800E-01
Stage1-vs-Stage2
9.783400E-01
Stage1-vs-Stage3
2.389600E-01
Stage1-vs-Stage4
3.739000E-01
Stage2-vs-Stage3
1.817160E-01
Stage2-vs-Stage4
4.460600E-01
Stage3-vs-Stage4
1.909400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.558800E-01
Normal-vs-AfricanAmerican
3.204200E-01
Normal-vs-Asian
2.941600E-01
Caucasian-vs-AfricanAmerican
8.482000E-01
Caucasian-vs-Asian
3.282000E-03
AfricanAmerican-vs-Asian
3.880400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.122400E-01
Normal-vs-Female
1.140400E-01
Male-vs-Female
1.720420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.543400E-01
Normal-vs-Age(41-60Yrs)
5.510400E-01
Normal-vs-Age(61-80Yrs)
4.080000E-01
Normal-vs-Age(81-100Yrs)
3.429200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.309200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.262000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.853200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.709700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.580400E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.658820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.253200E-01
Normal-vs-Daily Drinker
5.634200E-02
Normal-vs-Weekly Drinker
8.537600E-02
Normal-vs-Occasional Drinker
2.349800E-01
Normal-vs-Social Drinker
5.702000E-01
Non Drinker-vs-Daily Drinker
3.993400E-01
Non Drinker-vs-Weekly Drinker
5.246400E-01
Non Drinker-vs-Occasional Drinker
4.627800E-01
Non Drinker-vs-Social Drinker
1.657030E-01
Daily Drinker-vs-Weekly Drinker
9.151400E-01
Daily Drinker-vs-Occasional Drinker
2.163200E-01
Daily Drinker-vs-Social Drinker
7.334300E-02
Weekly Drinker-vs-Occasional Drinker
3.128400E-01
Weekly Drinker-vs-Social Drinker
1.158180E-01
Occasional Drinker-vs-Social Drinker
6.566000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.893600E-02
Normal-vs-Grade 2
3.631600E-02
Normal-vs-Grade 3
3.735500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.958200E-01
Grade 1-vs-Grade 3
3.700600E-01
Grade 1-vs-Grade 4
4.893600E-02
Grade 2-vs-Grade 3
4.596600E-01
Grade 2-vs-Grade 4
3.631600E-02
Grade 3-vs-Grade 4
3.735500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.853400E-01
Normal-vs-NonDiabetic
4.349600E-01
Diabetic-vs-NonDiabetic
3.357600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.350600E-01
Normal-vs-NoPancreatitis
4.041400E-01
Pancreatitis-vs-NoPancreatitis
1.945390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.191950E-01
Normal-vs-N1
4.450200E-01
N0-vs-N1
9.590000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.737600E-01
Normal-vs-TP53-NonMutant
5.444800E-01
TP53-Mutant-vs-TP53-NonMutant
1.291830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
